Table 10.
Effect of methanolic extract of Myrica nagi (MEMN) on mesenteric fat pad and perirenal fat in a high-fat diet (HFD) model.
| a | ||||||
|---|---|---|---|---|---|---|
| Control | Inducer | Standard | MEMN (100 mg/kg) | MEMN (200 mg/kg) | MEMN (400 mg/kg) | |
| Mesenteric Fat (gm) | 0.301 ± 1.76 | 1.823 ± 1.45### | 0.923 ± 1.89∗∗∗ | 1.6 ± 1.56∗∗ | 1.413 ± 1.4∗∗∗ | 1.215 ± 1.62∗∗∗ |
| b | ||||||
|---|---|---|---|---|---|---|
| Fat Pad Weight (gm) | Control | GTG | Orlistat | MEMN (100 mg/kg) | MEMN (200 mg/kg) | MEMN (400 mg/kg) |
| Mesenteric Fat | 0.56 ± 0.10 | 1.45 ± 0.10### | 0.92 ± 0.10∗∗∗ | 1.4 ± 0.10∗∗∗ | 1.31 ± 0.10∗∗∗ | 1.28 ± 0.10∗∗∗ |
| Epididymal Fat | 1.31 ± 1.54 | 2.85 ± 1.59### | 1.83 ± 1.45∗∗∗ | 2.51 ± 1.24∗∗∗ | 2.5 ± 1.54∗∗∗ | 2.2 ± 1.54∗∗∗ |
| Perirenal Fat | 0.61 ± 1.76 | 0.97 ± 1.45### | 0.81 ± 1.89∗∗∗ | 0.91 ± 1.56∗∗∗ | 0.89 ± 1.44∗∗∗ | 0.86 ± 1.62∗∗∗ |
Methanolic extract of M. nagi., MEMN; GTG., Gold thio glucose; p.o., per oral. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ###p < 0.001, #p < 0.05, ##p < 0.01, # When compared with normal control group, ∗ when compared with inducer group.